Status:
NO_LONGER_AVAILABLE
Expanded Access for Anti-IL8
Lead Sponsor:
Bristol-Myers Squibb
Brief Summary
This is an expanded access designed to provide access to Anti-IL8 for eligible participants.
Eligibility Criteria
Inclusion
Exclusion
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05210894
Last Update
May 16 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.